Construction of review indicators and analysis of obstacles and promoting factors for long-term oral anticoagulant management in patients with atrial fibrillation
10.3760/cma.j.cn211501-20240423-00999
- VernacularTitle:心房颤动患者长期口服抗凝药物管理审查指标制订及障碍和促进因素分析
- Author:
Jun LIU
1
;
Xiaoyan ZHAO
;
Songmei CAO
;
Liqun ZHU
;
Jiaojiao JIANG
;
Chengjie DONG
;
Fang WANG
Author Information
1. 江苏大学附属医院心内科，镇江 212001
- Publication Type:Journal Article
- Keywords:
Atrial fibrillation;
Oral anticoagulant;
Review indicators;
Obstacle factors;
Evidence translation
- From:
Chinese Journal of Practical Nursing
2025;41(6):452-458
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To evaluate the clinical status of long-term oral anticoagulant management in patients with atrial fibrillation, and to analyze the obstacles and promoting factors in the implementation of evidence, so as to provide evidence for clinical transformation.Methods:This study was a cross-sectional study. Through the evidence-based nursing method, guided by the Ottawa Model, the review indicators and review methods were developed based on the best evidence. The clinical status review of 100 patients who met the inclusion criteria in the Department of Cardiology, Affiliated Hospital of Jiangsu University was conducted from August to November 2022 using a convenience sampling method, and based on the results of the review, an analysis of obstacles and promoting factors was carried out to develop a clinical response.Results:This study included 100 patients with atrial fibrillation, 60 males and 40 females, aged (70.14 ± 10.39) years. Totally 26 best items were included, and 24 review indicators were developed, among which only 4 indicators had a compliance rate of 100% , 2 indicators had a compliance rate of >60% , 5 indicators had a compliance rate of <60% , and 13 indicators had a compliance rate of 0. According to the results of the review, a comprehensive and systematic analysis was conducted from the three dimensions of system, practitioners, patients and family members. For each dimension, obstacles and promoting factors were analyzed in depth from evidence-based change, potential adopters and practical environment.Conclusions:There is a gap between the best evidence and clinical status of long-term oral anticoagulant management in patients with atrial fibrillation. In-depth analysis of obstacle factors, formulate countermeasures, and promote the efficient implementation of evidence in clinical practice.
